Institute of Molecular genetics, Russian Academy of sciences have developed a new unique peptide based anxiolytic.
I am aware that many people are suffering from anxiety problems. This could be very useful to them.
I could not find much information about it. Most of the info is in Russian.
Automatic translation from their website:
anxiolytic drug action
SELANK - this regulatory peptide, a synthetic analogue of a short fragment of the heavy chain of human immunoglobulin G (tetrapeptid taftsin), extended tripeptidom Pro-Gly-Pro nootropnogo action. SELANK developed at the Institute of Molecular Genetics, Russian Academy of Sciences jointly with the Research Institute of Pharmacology them. VV Zakusova RAMS. SELANK has sustained and nootropnym anxiolytic effect and is effective in the treatment of patients with generalized anxiety disorder. SELANK advantage over the traditional benzodiazepinovyh tranquilizers (relaniuma, alprazolama, fenazepama, etc.) The lack of habituation and side effects (retardation, drowsiness, violations of concentration, memory and coordination of movements). SELANK practically harmless, even at doses 500 times higher than therapeutic. SELANK (0.15% aqueous solution) can be successfully applied to suppress the feelings of fear, anxiety in neurotic patients, to stimulate memory and learning in healthy people, neutralize the effects of stress, as well as for the prevention of mental fatigue and astenonevroticheskih disorders of different genesis.
Has completed phase III clinical trials the drug «Selank-0, 15% solution» in three psychiatric hospitals in Moscow, which take place at this time. Preliminary results of clinical studies confirm the findings of phase II clinical studies. There are currently prepared and submitted for approval by all regulatory documentation for the release of a new drug. A manufacturing base for production of the drug.
Drug «Selank-0, 15% solution» is unique and has no analogues abroad.
1. Anxiolytic pharmaceutical composition tool and anxiolytic action.
Patent number 2155065, issued on 27 August 2000.
2. The method of prevention and correction of immunodeficient states.
Patent, a positive decision of 27 June 2007.
Gold medal and a diploma at the international salon of innovations. Geneva, April 20, 2007 for peptide drug Selank - anksiolitik with nootropnym effect.
Some people think that I am affiliated with online Russian Pharmacies. I am not. SELANK is not in the market yet and no company sells it. POSTED FOR INFORMATIONAL PURPOSES ONLY ...
Edited by anony4mous, 12 September 2009 - 06:01 PM.